K-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome

scientific article published on 01 January 1998

K-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S004320050234
P698PubMed publication ID9879831

P50authorMarek CybulskiQ59705328
P2093author name stringJ Wojcierowski
W Baranowski
A Semczuk
H Berbeć
M Kostuch
P433issue12
P304page(s)695-700
P577publication date1998-01-01
P1433published inJournal of Cancer Research and Clinical OncologyQ2081599
P1476titleK-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome
P478volume124

Reverse relations

cites work (P2860)
Q36841899Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus
Q53352988Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
Q74116705Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis
Q34556688Expression of genes encoding extracellular matrix proteins: a macroarray study.
Q33781274Genetics of endometrial cancers
Q34541232High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated
Q74497110Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations
Q53402016K-ras exon 2 point mutations in human endometrial cancer
Q36616497K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
Q36451726KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
Q79124337Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis
Q35911350Personalized therapy in endometrial cancer: Challenges and opportunities
Q85076020Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer
Q73447336RB protein expression in human endometrial carcinomas--an immunohistochemical study
Q45072389TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas
Q35147597The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905
Q33689293The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer
Q73495885p53 protein detection by the western blotting technique in normal and neoplastic specimens of human endometrium

Search more.